People who received a fourth shot of Pfizer vaccine were 30 percent less likely to be infected than people who got three doses. Among the Moderna recipients, people were 18% less likely to get infected after a fourth shot.
But Regev-Yochay said that there is a stronger effect against symptomatic illness. Pfizer recipients were 43% less likely to develop symptomatic illness after a fourth shot, and among Moderna participants the figure was 31%.
She emphasized that her research was conducted on health workers under the retirement age, and therefore doesn’t give a picture of the fourth dose’s effectiveness for the elderly, which its main target in Israel and in some other countries, including the UK.
No comments:
Post a Comment
ANONYMOUS COMMENTS WILL NOT BE POSTED!
please use either your real name or a pseudonym.